Skip to main content
Perfusate for optimized gene delivery to donor organs undergoing ex vivo machine perfusion

Perfusate for optimized gene delivery to donor organs undergoing ex vivo machine perfusion

Unmet Need Effective gene delivery is notoriously difficult to achieve to an entire target organ. Gene therapies have traditionally been administered intravascularly, requiring high vector doses to attain therapeutic levels of expression. Because of this…

Read More

Biomaterial pouch for long-term xenogeneic cell transplantation

Biomaterial pouch for long-term xenogeneic cell transplantation

Unmet Need Cell therapy is an exciting therapeutic approach that is growing rapidly – there are more than 1,000 cell therapy clinical trials that are currently active in many different fields like oncology, neurology, hematology,…

Read More

Gene signature for prediction of acute rejection in kidney transplant

Gene signature for prediction of acute rejection in kidney transplant

Unmet Need Kidney transplant is the best current treatment for kidney failure. The kidney is the most common organ to be transplanted, and in 2019 there were 23,405 kidney transplants in the United States. Unfortunately,…

Read More

Methods for ablating niche cells in testis

Methods for ablating niche cells in testis

Value Proposition Infertility affects 10-15% of couples and up to 50% of these cases are due to the male partner. While the largest proportion (30%) of these cases are idiopathic with no known causes and…

Read More

Isolated organ viral, theraputic or cell therapy delivery

Isolated organ viral, theraputic or cell therapy delivery

Value proposition Cardiovascular diseases (CVD) remain the leading cause of death worldwide. The number of CVD patients with heart failure (HF) in the US is approaching 6.5 million adults and is estimated to increase by…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us